The study represents a repurposing strategy, using dupilumab as a tool compound to probe whether immune-targeted therapy can address a biologically defined subgroup of MDD.
James Murrough, MD, PhD
Advertisement
Articles by James Murrough, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Novel Botanical Moisturizer Demonstrates Superior Efficacy Over Metronidazole in Phase 2 Rosacea Trial
2
The Emerging Role of Oral Peptide Therapeutics in Dermatology
3
New Immune-Mediated Therapies in AD, Alopecia Areata, and HS Presented at SDNP
4
Translational Takeaways: June 7, 2026
5